Clin2
NCT03005132Possibly a fitRecruiting

Study for people with newly diagnosed brain cancer (GBM)

GBM

Part of Cancer clinical trials.

This trial looks at people with glioblastoma (GBM), a fast-growing brain tumor, to better understand it and how treatments might work. You may be able to join if you’re in a good general health range and have not had prior cancer chemotherapy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You are 75 years old or younger.
  • You have been diagnosed with glioblastoma (GBM) confirmed by pathology (a lab test of tissue).
  • Your overall health is not severely affected (no major organ dysfunction).
  • Your daily functioning is good (WHO performance status 0 or 1).
  • You have not received prior cancer chemotherapy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06936046Recruiting· Phase 2
Enhanced treatment for newly diagnosed GBM with partial resection or early progression

This trial tests a stronger combination of treatments given after surgery for people with glioblastoma (GBM) that was only partially removed or that starts growing again quickly. It aims to see if this approach can help control the tumor better. You may be eligible if you are newly diagnosed, over 18, have good organ function, and do not have other serious health issues.

Hangzhou
NCT07627334Recruiting
Personalized drug testing for newly diagnosed brain tumors

This trial tests whether customized drug screening on your tumor cells can help doctors choose the best treatment for you. Your tumor cells will be grown in the lab and tested against different drugs to find what works best, combined with short-course radiation therapy.

Vienna, State of Vienna
NCT05734560Recruiting· Phase 1/Phase 2
Study drug via brain catheter for newly diagnosed GBM

This Phase 1/2 trial tests two experimental treatments delivered through a thin catheter placed in the brain for people with newly diagnosed glioblastoma (GBM). The goal is to see whether the treatment can be given safely and whether it may shrink or control the tumor after standard chemotherapy and radiation.

Durham, North Carolina
NCT05775458Recruiting
Study of treatments for aggressive brain tumor cell damage

This study looks at glioblastoma (GBM), a very aggressive brain tumor, and how “brain cell overload” (glutamate excitotoxicity) may affect tumor growth. It focuses on adults who are planned for complete tumor removal, followed by standard radiation and chemotherapy.

Milan, Milan
NCT06625684Recruiting
Long-term study for glioblastoma patients

This study tracks people with glioblastoma (a type of aggressive brain tumor) over time to understand what affects their health and quality of life. If you take part, you'll fill out online surveys to help researchers learn how to improve care.

Durham, North Carolina
NCT03970447Recruiting· Phase 2/Phase 3
Testing several treatment options for new or returning glioblastoma

This trial studies different treatment regimens for people with glioblastoma that is either newly diagnosed or has come back. It aims to find which treatment approach works best for controlling the tumor and improving outcomes.

Birmingham, Alabama

Hear when a new GBM trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.